Metabolomics in drug research and development: The recent advances in technologies and applications

[1]  A. Vidal-Puig,et al.  Spatial metabolomics and its application in the liver , 2023, Hepatology.

[2]  M. Giera,et al.  Lipidomics analysis in drug discovery and development. , 2022, Current opinion in chemical biology.

[3]  W. Hang,et al.  High spatial resolution mass spectrometry imaging for spatial metabolomics: Advances, challenges, and future perspectives , 2022, TrAC Trends in Analytical Chemistry.

[4]  Q. Tan,et al.  Metabolomics of Extracellular Vesicles: A Future Promise of Multiple Clinical Applications , 2022, International journal of nanomedicine.

[5]  J. Loscalzo,et al.  Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease. , 2022, Cell metabolism.

[6]  Xin Ma,et al.  Advances in mass spectrometry imaging for spatial cancer metabolomics. , 2022, Mass spectrometry reviews.

[7]  R. Deberardinis,et al.  Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse , 2022, The Journal of clinical investigation.

[8]  Wei-Guo Zhu,et al.  Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth , 2022, Nature Cancer.

[9]  A. Regev,et al.  AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer , 2022, Cancer discovery.

[10]  R. Deberardinis,et al.  Metabolic analysis as a driver for discovery, diagnosis, and therapy , 2022, Cell.

[11]  Hong Wang,et al.  Global stable-isotope tracing metabolomics reveals system-wide metabolic alternations in aging Drosophila , 2022, Nature Communications.

[12]  Zheng-Jiang Zhu,et al.  Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking , 2022, bioRxiv.

[13]  Mohd Zuwairi Saiman,et al.  Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes , 2022, Pharmaceutics.

[14]  Der-Yen Lee,et al.  Recent advances in LC-MS-based metabolomics for clinical biomarker discovery. , 2022, Mass spectrometry reviews.

[15]  Guixin Wu,et al.  Metabolic characterization of hypertrophic cardiomyopathy in human heart , 2022, Nature Cardiovascular Research.

[16]  William A. Donald,et al.  Single-cell mass spectrometry. , 2022, Trends in biotechnology.

[17]  Zhiheng Xu,et al.  Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models , 2022, Cell discovery.

[18]  F. Matsuda,et al.  Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry , 2022, iScience.

[19]  N. Rothman,et al.  Circulatory metabolites trigger ex vivo arterial endothelial cell dysfunction in population chronically exposed to diesel exhaust , 2022, Particle and fibre toxicology.

[20]  Jiuming He,et al.  A temporo-spatial pharmacometabolomics method to characterize pharmacokinetics and pharmacodynamics in the brain microregions by using ambient mass spectrometry imaging , 2022, Acta pharmaceutica Sinica. B.

[21]  Ingela Lanekoff,et al.  Single-cell metabolomics: where are we and where are we going? , 2022, Current opinion in biotechnology.

[22]  Elizabeth K. Neumann,et al.  High Spatial Resolution MALDI Imaging Mass Spectrometry of Fresh-Frozen Bone. , 2022, Analytical chemistry.

[23]  Fan Yang,et al.  Comprehensive metabolomics expands precision medicine for triple-negative breast cancer , 2022, Cell Research.

[24]  Xiao-Fan Wang,et al.  Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression , 2022, Nature Cell Biology.

[25]  M. Giera,et al.  Recent advances in metabolomics analysis for early drug development. , 2022, Drug discovery today.

[26]  Xiaosong Rao,et al.  CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma , 2022, Molecular cancer.

[27]  D. Muddiman,et al.  Multimodal Mass Spectrometry Imaging of Rat Brain Using IR-MALDESI and NanoPOTS-LC-MS/MS. , 2021, Journal of proteome research.

[28]  John A. Bowden,et al.  Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring , 2021, Analytical chemistry.

[29]  Zeping Hu,et al.  Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma , 2021, Nature Communications.

[30]  Hu Li,et al.  Metabolic remodelling during early mouse embryo development , 2021, Nature Metabolism.

[31]  Z. Cai,et al.  Characterization and Determination of 13C-Labeled Nonessential Amino Acids in a 13C5-Glutamine Isotope Tracer Experiment with a Mass Spectrometry Strategy Combining Parallel Reaction Monitoring and Multiple Reaction Monitoring. , 2021, Analytical chemistry.

[32]  M. Orešič,et al.  Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests , 2021, Nature Reviews Gastroenterology & Hepatology.

[33]  Ana Rita Brochado,et al.  Bioaccumulation of therapeutic drugs by human gut bacteria , 2021, Nature.

[34]  Wei Chen,et al.  A Comprehensive Analysis of Metabolomics and Transcriptomics Reveals Novel Biomarkers and Mechanistic Insights on Lorlatinib Crosses the Blood-Brain Barrier , 2021, Frontiers in Pharmacology.

[35]  A. Vertes,et al.  Ambient Single-Cell Analysis and Native Tissue Imaging Using Laser-Ablation Electrospray Ionization Mass Spectrometry with Increased Spatial Resolution. , 2021, Journal of the American Society for Mass Spectrometry.

[36]  Shao Li,et al.  Aberrant NAD+ metabolism underlies Zika virus–induced microcephaly , 2021, Nature Metabolism.

[37]  Zeping Hu,et al.  Simultaneous 3-Nitrophenylhydrazine Derivatization Strategy of Carbonyl, Carboxyl and Phosphoryl Submetabolome for LC-MS/MS-Based Targeted Metabolomics with Improved Sensitivity and Coverage. , 2021, Analytical chemistry.

[38]  S. Schuster,et al.  Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices , 2021, Nature Methods.

[39]  Z. Ju,et al.  Metabolomic profiling of single enlarged lysosomes , 2021, Nature Methods.

[40]  Mahmoud A. Bassal,et al.  Metabolic alterations mediated by STAT3 promotes drug persistence in CML , 2021, Leukemia.

[41]  Imhoi Koo,et al.  Current Challenges and Recent Developments in Mass Spectrometry-Based Metabolomics. , 2021, Annual review of analytical chemistry.

[42]  M. Heikenwalder,et al.  SpaceM reveals metabolic states of single cells , 2021, Nature Methods.

[43]  A. Brandis,et al.  β-sitosterol reduces anxiety and synergizes with established anxiolytic drugs in mice , 2021, Cell reports. Medicine.

[44]  Liang Liu,et al.  Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy , 2021, Gut.

[45]  Michael J. Lukey,et al.  Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy. , 2021, Trends in cancer.

[46]  Yanhua Chen,et al.  Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging , 2021, Acta pharmaceutica Sinica. B.

[47]  Shao Li,et al.  Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications , 2021, Nature communications.

[48]  Michael J Taylor,et al.  Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics , 2021, Journal of the American Society for Mass Spectrometry.

[49]  Zbynek Bozdech,et al.  Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival , 2021, Nature Communications.

[50]  M. Konopleva,et al.  The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells , 2020, Frontiers in Oncology.

[51]  M. Antoniewicz.  A guide to metabolic flux analysis in metabolic engineering: Methods, tools and applications. , 2020, Metabolic engineering.

[52]  P. Turnbaugh,et al.  Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. , 2020, Cell host & microbe.

[53]  B. Heijs,et al.  MALDI-2 for the Enhanced Analysis of N-Linked Glycans by Mass Spectrometry Imaging , 2020, Analytical chemistry.

[54]  Ge Yang,et al.  Dynamic organization of intracellular organelle networks. , 2020, Wiley interdisciplinary reviews. Systems biology and medicine.

[55]  Zhiguang Sun,et al.  Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis , 2020, Theranostics.

[56]  Zhiwei Zhou,et al.  Ion mobility collision cross-section atlas for known and unknown metabolite annotation in untargeted metabolomics , 2020, Nature Communications.

[57]  B. Xi,et al.  Comprehensive Isotopic Targeted Mass Spectrometry (CIT-MS): Reliable Metabolic Flux Analysis with Broad Coverage. , 2020, Analytical chemistry.

[58]  J. Montaner,et al.  Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke , 2020, Nature Reviews Neurology.

[59]  S. Benkovic,et al.  Metabolomics and mass spectrometry imaging reveal channeled de novo purine synthesis in cells , 2020, Science.

[60]  Zebao He,et al.  Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.

[61]  A. Potapov,et al.  Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS* , 2020, Molecular & Cellular Proteomics.

[62]  F. Cheng,et al.  Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. , 2019, The Journal of clinical investigation.

[63]  Z. Abliz,et al.  In situ metabolomics in nephrotoxicity of aristolochic acids based on air flow-assisted desorption electrospray ionization mass spectrometry imaging , 2019, Acta pharmaceutica Sinica. B.

[64]  W. Hang,et al.  Perspective on Advances in Laser-based High-Resolution Mass Spectrometry Imaging. , 2019, Analytical chemistry.

[65]  Jun Jiang,et al.  Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation , 2019, Gut.

[66]  Weidong Zhang,et al.  Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid , 2019, Journal of pharmaceutical analysis.

[67]  H. Kung,et al.  Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor. , 2019, Molecular cell.

[68]  P. Siljander,et al.  Metabolomics Applied to the Study of Extracellular Vesicles , 2019, Metabolites.

[69]  D. Wishart.  Metabolomics for Investigating Physiological and Pathophysiological Processes. , 2019, Physiological reviews.

[70]  Zhe Wang,et al.  Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline , 2019, Proceedings of the National Academy of Sciences.

[71]  Wei Jia,et al.  Emerging Applications of Metabolomics in Clinical Pharmacology , 2019, Clinical pharmacology and therapeutics.

[72]  Christopher P. Long,et al.  High-resolution 13C metabolic flux analysis , 2019, Nature Protocols.

[73]  Jianfa Zhang,et al.  Adenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes , 2019, Diabetologia.

[74]  E. Henske,et al.  Metabolic Changes in Lymphangioleiomyomatosis Patients Treated with Sirolimus and Hydroxychloroquine. , 2019, Chest.

[75]  F. Gonzalez,et al.  Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity , 2019, British journal of pharmacology.

[76]  M. Zampieri,et al.  Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies , 2019, Molecular cell.

[77]  Abena B. Redwood,et al.  6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers , 2019, Clinical Cancer Research.

[78]  Markus M. Rinschen,et al.  Identification of bioactive metabolites using activity metabolomics , 2019, Nature Reviews Molecular Cell Biology.

[79]  B. Lim,et al.  Methionine is a metabolic dependency of tumor-initiating cells , 2019, Nature Medicine.

[80]  Xin Xiong,et al.  Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics , 2019, Nature Communications.

[81]  Eric C Greenwald,et al.  Genetically Encoded Fluorescent Biosensors Illuminate the Spatiotemporal Regulation of Signaling Networks. , 2018, Chemical reviews.

[82]  L. Tenori,et al.  High‐Throughput Metabolomics by 1D NMR , 2018, Angewandte Chemie.

[83]  Ho-Joon Lee,et al.  Macrophage Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer , 2018, bioRxiv.

[84]  R. Loomba,et al.  GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease. , 2018, Gastroenterology.

[85]  Fergus Gleeson,et al.  Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer , 2018, Cell metabolism.

[86]  W. Liu,et al.  Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome , 2018, Science Translational Medicine.

[87]  Fengguo Xu,et al.  Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan , 2018, Acta pharmaceutica Sinica. B.

[88]  R. Deberardinis,et al.  Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers. , 2018, Cell metabolism.

[89]  Zeper Abliz,et al.  Combination of Droplet Extraction and Pico-ESI-MS Allows the Identification of Metabolites from Single Cancer Cells. , 2018, Analytical chemistry.

[90]  Hongyuan Chen,et al.  Vacuum Ultraviolet Laser Desorption/Ionization Mass Spectrometry Imaging of Single Cells with Submicron Craters. , 2018, Analytical chemistry.

[91]  G. Kroemer,et al.  Metabolic vulnerability of cisplatin‐resistant cancers , 2018, The EMBO journal.

[92]  R. Collins,et al.  Durable Remissions with Ivosidenib in IDH1‐Mutated Relapsed or Refractory AML , 2018, The New England journal of medicine.

[93]  Lichao Wang,et al.  Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography–Mass Spectrometry , 2018, Analytical chemistry.

[94]  T. Meyer,et al.  Combined Human Genome-wide RNAi and Metabolite Analyses Identify IMPDH as a Host-Directed Target against Chlamydia Infection. , 2018, Cell host & microbe.

[95]  J. Rabinowitz,et al.  Metabolomics and Isotope Tracing , 2018, Cell.

[96]  Pramod P Wangikar,et al.  SWATH Tandem Mass Spectrometry Workflow for Quantification of Mass Isotopologue Distribution of Intracellular Metabolites and Fragments Labeled with Isotopic 13C Carbon. , 2018, Analytical chemistry.

[97]  Jason H. Yang,et al.  Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function. , 2017, Cell host & microbe.

[98]  T. Hankemeier,et al.  Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine. , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[99]  T. Hankemeier,et al.  Multivariate pharmacokinetic/pharmacodynamic (PKPD) analysis with metabolomics shows multiple effects of remoxipride in rats , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[100]  P. Siegel,et al.  PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs. , 2017, Cell metabolism.

[101]  Neel S Madhukar,et al.  A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product. , 2017, Cell metabolism.

[102]  O. Fiehn,et al.  Metabolite Measurement: Pitfalls to Avoid and Practices to Follow. , 2017, Annual Review of Biochemistry.

[103]  J. Loscalzo,et al.  Genetically encoded fluorescent sensors reveal dynamic regulation of NADPH metabolism , 2017, Nature Methods.

[104]  I. Flinn,et al.  Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. , 2017, Blood.

[105]  Hua Yang,et al.  AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations. , 2017, Cancer discovery.

[106]  J. Locasale,et al.  Metabolomics: A Primer. , 2017, Trends in biochemical sciences.

[107]  S. Choquet,et al.  Endogenous metabolites that are substrates of organic anion transporter's (OATs) predict methotrexate clearance , 2017, Pharmacological research.

[108]  C. Newgard,et al.  Metabolomics and Metabolic Diseases: Where Do We Stand? , 2017, Cell metabolism.

[109]  C. Dang,et al.  From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.

[110]  E. Lengyel,et al.  Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers. , 2016, Cell metabolism.

[111]  Takashi Tsukamoto,et al.  Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer , 2016, Proceedings of the National Academy of Sciences.

[112]  Jin‐Ming Lin,et al.  Single-Cell Analysis Using Drop-on-Demand Inkjet Printing and Probe Electrospray Ionization Mass Spectrometry. , 2016, Analytical chemistry.

[113]  Caroline H. Johnson,et al.  Metabolomics: beyond biomarkers and towards mechanisms , 2016, Nature Reviews Molecular Cell Biology.

[114]  D. Wishart.  Emerging applications of metabolomics in drug discovery and precision medicine , 2016, Nature Reviews Drug Discovery.

[115]  J. Jara,et al.  Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity. , 2015, Pharmacological research.

[116]  Nicola Zamboni,et al.  Defining the metabolome: size, flux, and regulation. , 2015, Molecular cell.

[117]  E. Mittra,et al.  Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors. , 2015 .

[118]  F. Cheng,et al.  SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents. , 2015, Cell metabolism.

[119]  K. Struhl,et al.  Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells , 2014, Proceedings of the National Academy of Sciences.

[120]  Prasad Kulkarni,et al.  How Drugs are Developed and Approved by the FDA: Current Process and Future Directions , 2014, The American Journal of Gastroenterology.

[121]  Jennifer B Dennison,et al.  Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.

[122]  R Zenobi,et al.  Single-Cell Metabolomics: Analytical and Biological Perspectives , 2013, Science.

[123]  Xin Lu,et al.  Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry. , 2013, Analytical chemistry.

[124]  A. Iafrate,et al.  Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. , 2012, Blood.

[125]  D. Margolis,et al.  Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. , 2012, Blood.

[126]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[127]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[128]  J. Loscalzo,et al.  Genetically encoded fluorescent sensors for intracellular NADH detection. , 2011, Cell metabolism.

[129]  Dinesh Rakheja,et al.  2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients , 2011, Nature Medicine.

[130]  Roman M. Balabin,et al.  Single-cell MALDI-MS as an analytical tool for studying intrapopulation metabolic heterogeneity of unicellular organisms. , 2010, Analytical chemistry.

[131]  Omar Abdel-Wahab,et al.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.

[132]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[133]  William J. Griffiths,et al.  Mass spectrometry: from proteomics to metabolomics and lipidomics. , 2009, Chemical Society reviews.

[134]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[135]  Elaine Holmes,et al.  The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.

[136]  D. Wishart.  Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.